M, M., F, L., ML, H., L, G., G, B., C, M., . . . TN, C. (2021). Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial. Trials, 22(1), 131. https://doi.org/10.1186/s13063-021-05095-x
Chicago Style (17th ed.) CitationM, Muller, et al. "Impact of Intravenous Lidocaine on Clinical Outcomes of Patients with ARDS During COVID-19 Pandemia (LidoCovid): A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Trials 22, no. 1 (2021): 131. https://doi.org/10.1186/s13063-021-05095-x.
MLA (9th ed.) CitationM, Muller, et al. "Impact of Intravenous Lidocaine on Clinical Outcomes of Patients with ARDS During COVID-19 Pandemia (LidoCovid): A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Trials, vol. 22, no. 1, 2021, p. 131, https://doi.org/10.1186/s13063-021-05095-x.